Location [1]
Protein [2]
RAC-beta serine/threonine-protein kinase
Synonyms [1]

V-akt murine thymoma viral oncogene homolog 2 (AKT2) is a gene that encodes a protein serine/threonine kinase with a SH2-like domain. Missense mutations, nonsense mutations, silent mutations, and in-frame deletions are observed in cancers such as endometrial cancer, intestinal cancer, and stomach cancer.

AKT2 is altered in 1.56% of all cancers with breast carcinoma, non-small cell lung carcinoma, colorectal adenocarcinoma, ovarian neoplasm, and uterine corpus neoplasm having the greatest prevalence of alterations [3].

AKT2 GENIE Cases - Top Diseases

The most common alterations in AKT2 are AKT2 Amplification (0.95%), AKT2 Mutation (0.70%), AKT2 Mutation (somatic) (0.70%), AKT2 Loss (0.04%), and AKT2 E17K (0.03%) [3].

AKT2 GENIE Cases - Top Alterations

Significance of AKT2 in Diseases

Malignant Solid Tumor +

Breast Carcinoma +

Non-Small Cell Lung Carcinoma +

Non-Hodgkin Lymphoma +

Squamous Cell Lung Carcinoma +

Endometrial Carcinoma +

Prostate Carcinoma +

Pancreatic Carcinoma +

Small Cell Lung Carcinoma +

Melanoma +

Renal Cell Carcinoma +

Glioblastoma +

Head And Neck Squamous Cell Carcinoma +

Gastric Adenocarcinoma +

Thyroid Gland Carcinoma +

Colorectal Carcinoma +

Hepatocellular Carcinoma +

Cholangiocarcinoma +

B-Cell Non-Hodgkin Lymphoma +

Cancer +

Histiocytic And Dendritic Cell Neoplasm +

Multiple Myeloma +

Ovarian Carcinoma +

Peritoneal Mesothelioma +

Thymic Carcinoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20170629. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.